Wyoming
Requires Coverage of Comprehensive Biomarker Testing
No
Highlighted Disparity
No racial disparities were found in Wyoming for these lung cancer metrics
Lung Cancer Rates
New Cases:
- The rate of new lung cancer cases in Wyoming is 38.4 and significantly lower than the national rate of 52.8.
 - It ranks 6th among all states, placing it in the above average tier.
 - Over the last five years, the rate of new cases in Wyoming did not change significantly.
 - In 2022, the most recent year of data available for this report, the COVID-19 pandemic continued to disrupt access to medical care, including delays and reductions in cancer diagnoses and screening. This led to a decline in incidence rates for most cancers, including lung cancer, and should not be interpreted as a reduction in the underlying cancer burden.
 
5-Year Survival Rate:
- The percent of people alive five years after being diagnosed with lung cancer in Wyoming is 24.8%, which is significantly lower than the national rate of 29.7%.
 - It ranks 34th among the 39 states with survival data, placing it in the bottom tier.
 - Over the last five years, the survival rate in Wyoming did not change significantly.
 
Early Diagnosis:
- In Wyoming, 29.8% of cases are caught at an early stage, which is not significantly different than the national rate of 28.1%.
 - It ranks 16th among the 50 states with data on diagnosis at an early stage, placing it in the above average tier.
 - Over the last five years, the early diagnosis rate in Wyoming did not change significantly.
 
Lung Cancer Treatment
Biomarker Coverage:
- Wyoming has yet to require any insurance coverage of comprehensive biomarker testing, including for lung cancer, as of August 2025.
 
Surgical Treatment:
- Wyoming ranked 43rd (out of the 49 states with available data) with 15.9% of cases undergoing surgery as part of the first course of treatment, which is significantly lower than the national rate of 20.7%.
 - It puts Wyoming in the bottom tier.
 - Over the last five years, the percent of cases undergoing surgery in Wyoming did not change significantly.
 
No Treatment:
- Wyoming ranked 35th (out of the 49 states with available data) with 22.4% of cases not receiving any treatment, which is not significantly different than the national rate of 21.0%.
 - It puts Wyoming in the average tier.
 - Over the last five years, the percent of cases receiving no treatment in Wyoming did not change significantly.
 
Screening
Screening for High Risk:
- In Wyoming, 9.7% of those at high risk were screened, which was significantly lower than the national rate of 18.2%.
 - It ranks 51st among all states, placing it in the bottom tier.
 - Screening rates in this year’s report have been updated to correct an error in the data source and should not be compared to previous reports.
 
Prevention
Tobacco Use:
- The 2023 smoking rate in Wyoming is 14.0% and significantly higher than the national rate of 11.4%.
 - It ranks 35th among all states, placing it in the below average tier.
 
Radon Exposure:
- In Wyoming, 44.5% of radon tests results were at or above the action level recommended by EPA.
 - It ranks 43rd among all states, placing it in the below average tier.
 
Racial & Ethnic Disparities
Black Individuals:
- Lung cancer rates are not available for Black individuals in Wyoming due to too few cases over the time period to allow for accurate analysis.
 
Latino individuals:
- The rate of new lung cancer cases is 33.2 per 100,000 population among Latino individuals in Wyoming, not significantly different than the rate of 27.9 among Latino individuals nationally, and not significantly different than the rate of 39.0 among white individuals in Wyoming.
 - State-level survival rates are not available for Latino individuals at this time. Nationally, the five-year survival rate among Latino individuals is 22.7%, not significantly different than the rate of 25.0% among white individuals.
 - Other lung cancer rates are not available for Latino individuals in Wyoming due to too few cases over the time period to allow for accurate analysis.
 
Asian or Pacific Islander individuals:
- Lung cancer rates are not available for Asian or Pacific Islander individuals in Wyoming due to too few cases over the time period to allow for accurate analysis.
 
Indigenous Peoples:
- The rate of new lung cancer cases is 36.4 per 100,000 population among Indigenous peoples (American Indians/Alaska Natives) in Wyoming, not significantly different than the rate of 39.8 among Indigenous Peoples nationally, and not significantly different than the rate of 39.0 among white individuals in Wyoming.
 - State-level survival rates are not available for Indigenous Peoples at this time. Nationally, the five-year survival rate among Indigenous Peoples is 22.3% and not significantly different than the rate of 25.0% among white individuals.
 - Other lung cancer rates are not available for Indigenous Peoples (American Indians/Alaska Natives) in Wyoming due to too few cases over the time period to allow for accurate analysis.
 
Summary
Despite the early diagnosis rate in Wyoming falling into the above average tier, the state still has a lot of work to do to make sure that more of those at high risk for lung cancer are screened.
Wyoming has yet to require any insurance coverage of comprehensive biomarker testing, which can help determine what treatment options would be best for individuals with lung cancer and other diseases.
Wyoming falls into the average tier for percent of patients receiving no treatment. Some patients do refuse treatment, but issues such as fatalism and stigma can prevent eligible patients from accessing treatment that may save or extend their lives. All patients should work with their doctors to establish a treatment plan and goals.
Page last updated: October 29, 2025
